{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T00:56:26Z","timestamp":1784249786368,"version":"3.55.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T00:00:00Z","timestamp":1752537600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Metabolism"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.molmet.2025.102218","type":"journal-article","created":{"date-parts":[[2025,7,22]],"date-time":"2025-07-22T16:46:25Z","timestamp":1753202785000},"page":"102218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Inhibition of pyrimidine de novo synthesis fosters Treg cells and reduces diabetes development in models of Type 1 Diabetes"],"prefix":"10.1016","volume":"100","author":[{"given":"Hannah","family":"Hipp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Tondello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Gmehling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena K.","family":"Scholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antigoni","family":"Stavridou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maike","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie","family":"B\u00fchrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edith","family":"Hintermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra M.","family":"Dirschl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Till M.","family":"Johannsmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin G.","family":"Scherm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hella","family":"Kohlhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Serr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urs","family":"Christen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolin","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.molmet.2025.102218_bib1","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s00125-018-4763-3","article-title":"Trends and cyclical variation in the incidence of childhood type 1 diabetes in 26 European centres in the 25 year period 1989-2013: a multicentre prospective registration study","volume":"62","author":"Patterson","year":"2019","journal-title":"Diabetologia"},{"issue":"7293","key":"10.1016\/j.molmet.2025.102218_bib2","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1038\/nature08933","article-title":"Genetics, pathogenesis and clinical interventions in type 1 diabetes","volume":"464","author":"Bluestone","year":"2010","journal-title":"Nature"},{"issue":"23","key":"10.1016\/j.molmet.2025.102218_bib3","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1001\/jama.2013.6285","article-title":"Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children","volume":"309","author":"Ziegler","year":"2013","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.molmet.2025.102218_bib4","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.2337\/dc15-1419","article-title":"Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association","volume":"38","author":"Insel","year":"2015","journal-title":"Diabetes Care"},{"issue":"10146","key":"10.1016\/j.molmet.2025.102218_bib5","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0140-6736(18)31506-X","article-title":"Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study","volume":"392","author":"Rawshani","year":"2018","journal-title":"Lancet"},{"issue":"583","key":"10.1016\/j.molmet.2025.102218_bib6","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abc8980","article-title":"Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals","volume":"13","author":"Sims","year":"2021","journal-title":"Sci Transl Med"},{"issue":"5","key":"10.1016\/j.molmet.2025.102218_bib7","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s40265-023-01847-y","article-title":"Teplizumab: first approval","volume":"83","author":"Keam","year":"2023","journal-title":"Drugs"},{"issue":"4","key":"10.1016\/j.molmet.2025.102218_bib8","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ni904","article-title":"Foxp3 programs the development and function of CD4+CD25+ regulatory T cells","volume":"4","author":"Fontenot","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.molmet.2025.102218_bib9","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","article-title":"Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases","volume":"155","author":"Sakaguchi","year":"1995","journal-title":"J Immunol"},{"issue":"5609","key":"10.1016\/j.molmet.2025.102218_bib10","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1126\/science.1079490","article-title":"Control of regulatory T cell development by the transcription factor Foxp3","volume":"299","author":"Hori","year":"2003","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.molmet.2025.102218_bib11","doi-asserted-by":"crossref","first-page":"5697","DOI":"10.1038\/s41467-019-13587-3","article-title":"miRNA142-3p targets Tet2 and impairs Treg differentiation and stability in models of type 1 diabetes","volume":"10","author":"Scherm","year":"2019","journal-title":"Nat Commun"},{"issue":"422","key":"10.1016\/j.molmet.2025.102218_bib12","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aag1782","article-title":"A miRNA181aNFAT5 axis links impaired T cell tolerance induction with autoimmune type 1 diabete","volume":"10","author":"Serr","year":"2018","journal-title":"Sci Transl Med"},{"issue":"2","key":"10.1016\/j.molmet.2025.102218_bib13","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0020-711X(83)90051-4","article-title":"Purine and pyrimidine metabolism in peripheral blood lymphocytes","volume":"15","author":"Peters","year":"1983","journal-title":"Int J Biochem"},{"issue":"50","key":"10.1016\/j.molmet.2025.102218_bib14","doi-asserted-by":"crossref","first-page":"29682","DOI":"10.1074\/jbc.270.50.29682","article-title":"Importance of ribonucleotide availability to proliferating T-lymphocytes from healthy humans. Disproportionate expansion of pyrimidine pools and contrasting effects of de novo synthesis inhibitors","volume":"270","author":"Fairbanks","year":"1995","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.molmet.2025.102218_bib15","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s40268-019-00286-z","article-title":"The selective oral immunomodulator vidofludimus in patients with active rheumatoid arthritis: safety results from the COMPONENT Study","volume":"19","author":"Muehler","year":"2019","journal-title":"Drugs R&D"},{"issue":"32","key":"10.1016\/j.molmet.2025.102218_bib16","doi-asserted-by":"crossref","first-page":"33035","DOI":"10.1074\/jbc.R400007200","article-title":"Mammalian pyrimidine biosynthesis: fresh insights into an Ancient pathway","volume":"279","author":"Evans","year":"2004","journal-title":"J Biol Chem"},{"issue":"7","key":"10.1016\/j.molmet.2025.102218_bib17","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/acn3.51574","article-title":"A double-blind, randomized, placebo-controlled phase 2 trial evaluating the selective dihydroorotate dehydrogenase inhibitor vidofludimus calcium in relapsing-remitting multiple sclerosis","volume":"9","author":"Fox","year":"2022","journal-title":"Ann Clin Transl Neurol"},{"issue":"7","key":"10.1016\/j.molmet.2025.102218_bib18","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1182\/bloodadvances.2018027227","article-title":"Leflunomide regulates c-Myc expression in myeloma cells through PIM targeting","volume":"3","author":"Buettner","year":"2019","journal-title":"Blood Adv"},{"issue":"4","key":"10.1016\/j.molmet.2025.102218_bib19","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.4049\/jimmunol.160.4.1581","article-title":"Inhibition of JAK3 and STAT6 tyrosine phosphorylation by the immunosuppressive drug leflunomide leads to a block in IgG1 production","volume":"160","author":"Siemasko","year":"1998","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.molmet.2025.102218_bib20","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/cpdd.1243","article-title":"Safety, tolerability, and pharmacokinetics of IMU-935, a novel inverse agonist of retinoic acid receptor-related orphan nuclear receptor gammat: results from a double-Blind, placebo-controlled, first-in-human phase 1 study","volume":"12","author":"Polasek","year":"2023","journal-title":"Clin Pharmacol Drug Dev"},{"key":"10.1016\/j.molmet.2025.102218_bib21","series-title":"Poster presented at the 2nd conference on molecular mechanisms of inflammation","article-title":"IMU-935: orally available small molecule inhibitor of IL-17 with unique molecular profile for the treatment of autoimmune diseases","author":"Kohlhof","year":"2019"},{"issue":"6","key":"10.1016\/j.molmet.2025.102218_bib22","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1084\/jem.20080034","article-title":"In vivo equilibrium of proinflammatory IL-17+ and regulatory IL-10+ Foxp3+ RORgamma t+ T cells","volume":"205","author":"Lochner","year":"2008","journal-title":"J Exp Med"},{"issue":"6251","key":"10.1016\/j.molmet.2025.102218_bib23","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1126\/science.aac4263","article-title":"The microbiota regulates type 2 immunity through ROR\u03b3t+ T cells","volume":"349","author":"Ohnmacht","year":"2015","journal-title":"Science"},{"issue":"6251","key":"10.1016\/j.molmet.2025.102218_bib24","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1126\/science.aaa9420","article-title":"Individual intestinal symbionts induce a distinct population of ROR\u03b3+ regulatory T cells","volume":"349","author":"Sefik","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.molmet.2025.102218_bib25","series-title":"Poster presented at the 16th world immune regulation meeting","article-title":"IMU-935 a potent RORgt inverse agonist effectively inhibits T helper 17 cells but maintains normal thymocyte development","author":"Peelen","year":"2022"},{"issue":"10","key":"10.1016\/j.molmet.2025.102218_bib26","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1002\/ibd.21264","article-title":"4SC-101, a novel immunosuppressive drug, inhibits IL-17 and attenuates colitis in two murine models of inflammatory bowel disease","volume":"16","author":"Fitzpatrick","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.molmet.2025.102218_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102129","article-title":"Vidofludimus calcium, a next generation DHODH inhibitor for the Treatment of relapsing-remitting multiple sclerosis","volume":"43","author":"Muehler","year":"2020","journal-title":"Mult Scler Relat Disord"},{"issue":"1","key":"10.1016\/j.molmet.2025.102218_bib28","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/eji.200636435","article-title":"Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells","volume":"37","author":"Wang","year":"2007","journal-title":"Eur J Immunol"},{"issue":"12","key":"10.1016\/j.molmet.2025.102218_bib29","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/ni1265","article-title":"Inducing and expanding regulatory T cell populations by foreign antigen","volume":"6","author":"Kretschmer","year":"2005","journal-title":"Nat Immunol"},{"issue":"6","key":"10.1016\/j.molmet.2025.102218_bib30","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.cell.2006.07.035","article-title":"The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells","volume":"126","author":"Ivanov","year":"2006","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.molmet.2025.102218_bib31","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ddmod.2009.03.008","article-title":"Mouse Models for Type 1 Diabetes","volume":"6","author":"Van Belle","year":"2009","journal-title":"Drug Discov Today Dis Model"},{"issue":"1","key":"10.1016\/j.molmet.2025.102218_bib32","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jaut.2009.08.001","article-title":"Viral triggers for autoimmunity: is the 'glass of molecular mimicry' half full or half empty?","volume":"34","author":"Christen","year":"2010","journal-title":"J Autoimmun"},{"issue":"2","key":"10.1016\/j.molmet.2025.102218_bib33","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0092-8674(91)90165-U","article-title":"Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response","volume":"65","author":"Oldstone","year":"1991","journal-title":"Cell"},{"issue":"75","key":"10.1016\/j.molmet.2025.102218_bib34","article-title":"Accelerated type 1 diabetes induction in mice by adoptive transfer of diabetogenic CD4+ T cells","author":"Berry","year":"2013","journal-title":"JoVE J"},{"issue":"490","key":"10.1016\/j.molmet.2025.102218_bib35","doi-asserted-by":"crossref","first-page":"eaao5563","DOI":"10.1126\/scitranslmed.aao5563","article-title":"Teriflunomide treatment for multiple sclerosis modulates T cell mitochondrial respiration with affinity-dependent effects","volume":"11","author":"Klotz","year":"2019","journal-title":"Sci Transl Med"},{"issue":"3","key":"10.1016\/j.molmet.2025.102218_bib36","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41590-023-01436-x","article-title":"Pyrimidine de novo synthesis inhibition selectively blocks effector but not memory T cell development","volume":"24","author":"Scherer","year":"2023","journal-title":"Nat Immunol"},{"issue":"9","key":"10.1016\/j.molmet.2025.102218_bib37","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1021\/cb3002649","article-title":"Identification of a selective RORgamma ligand that suppresses T(H)17 cells and stimulates T regulatory cells","volume":"7","author":"Solt","year":"2012","journal-title":"ACS Chem Biol"},{"issue":"1","key":"10.1016\/j.molmet.2025.102218_bib38","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-90497-9","article-title":"Preclinical and clinical characterization of the RORgammat inhibitor JNJ-61803534","volume":"11","author":"Xue","year":"2021","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.molmet.2025.102218_bib39","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1139\/Y09-094","article-title":"Leflunomide induces immunosuppression in collagen-induced arthritis rats by upregulating CD4+CD25+ regulatory T cells","volume":"88","author":"Wang","year":"2010","journal-title":"Can J Physiol Pharmacol"},{"issue":"23","key":"10.1016\/j.molmet.2025.102218_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/molecules27238471","article-title":"Effect of IL-27, teriflunomide and retinoic acid and their combinations on CD4(+) T regulatory T Cells-An In vitro Study","volume":"27","author":"Maslanka","year":"2022","journal-title":"Molecules"},{"issue":"7559","key":"10.1016\/j.molmet.2025.102218_bib41","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nature14452","article-title":"Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation","volume":"523","author":"Gagliani","year":"2015","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.molmet.2025.102218_bib42","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1038\/s41467-020-17097-5","article-title":"The induction and function of the anti-inflammatory fate of TH17 cells","volume":"11","author":"Xu","year":"2020","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.molmet.2025.102218_bib43","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.immuni.2008.05.007","article-title":"Molecular antagonism and plasticity of regulatory and inflammatory T cell programs","volume":"29","author":"Yang","year":"2008","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.molmet.2025.102218_bib44","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1371\/journal.pbio.0050038","article-title":"Epigenetic control of the foxp3 Locus in regulatory T cells","volume":"5","author":"Floess","year":"2007","journal-title":"PLoS Biol"},{"key":"10.1016\/j.molmet.2025.102218_bib45","doi-asserted-by":"crossref","DOI":"10.1002\/eji.201948435","article-title":"Pharmacological inhibition of RORC2 enhances human Th17-Treg stability and function","author":"Boardman","year":"2020","journal-title":"Eur J Immunol"},{"issue":"6","key":"10.1016\/j.molmet.2025.102218_bib46","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.4049\/jimmunol.0900146","article-title":"Immune suppressive activity and lack of T helper differentiation are differentially regulated in natural regulatory T cells","volume":"183","author":"Zeng","year":"2009","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.molmet.2025.102218_bib47","doi-asserted-by":"crossref","first-page":"216","DOI":"10.4049\/jimmunol.1101215","article-title":"IL-17 silencing does not protect nonobese diabetic mice from autoimmune diabetes","volume":"188","author":"Joseph","year":"2012","journal-title":"J Immunol"},{"issue":"28","key":"10.1016\/j.molmet.2025.102218_bib48","doi-asserted-by":"crossref","first-page":"11548","DOI":"10.1073\/pnas.1108924108","article-title":"Naturally transmitted segmented filamentous bacteria segregate with diabetes protection in nonobese diabetic mice","volume":"108","author":"Kriegel","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"10.1016\/j.molmet.2025.102218_bib49","doi-asserted-by":"crossref","first-page":"4779","DOI":"10.4049\/jimmunol.0902822","article-title":"Th17 polarized cells from nonobese diabetic mice following mycobacterial adjuvant immunotherapy delay type 1 diabetes","volume":"184","author":"Nikoopour","year":"2010","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.molmet.2025.102218_bib50","doi-asserted-by":"crossref","first-page":"2840","DOI":"10.2353\/ajpath.2010.091227","article-title":"4SC-101, a novel small molecule dihydroorotate dehydrogenase inhibitor, suppresses systemic lupus erythematosus in MRL-(Fas)lpr mice","volume":"176","author":"Kulkarni","year":"2010","journal-title":"Am J Pathol"},{"issue":"5","key":"10.1016\/j.molmet.2025.102218_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102494","article-title":"DHODH inhibition modulates glucose metabolism and circulating GDF15, and improves metabolic balance","volume":"24","author":"Zhang","year":"2021","journal-title":"iScience"},{"issue":"2","key":"10.1016\/j.molmet.2025.102218_bib52","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.cmet.2019.12.005","article-title":"Comprehensive proteomics analysis of stressed human islets identifies GDF15 as a target for type 1 diabetes intervention","volume":"31","author":"Nakayasu","year":"2020","journal-title":"Cell Metab"},{"issue":"7","key":"10.1016\/j.molmet.2025.102218_bib53","doi-asserted-by":"crossref","first-page":"4481","DOI":"10.4049\/jimmunol.166.7.4481","article-title":"IFN-\u03b3\/TNF-\u03b1 synergism as the final effector in autoimmune diabetes: a key role for STAT1\/IFN regulatory Factor-1 pathway in pancreatic \u03b2 cell death","volume":"166","author":"Suk","year":"2001","journal-title":"J Immunol"},{"issue":"21","key":"10.1016\/j.molmet.2025.102218_bib54","doi-asserted-by":"crossref","first-page":"12191","DOI":"10.1073\/pnas.211445998","article-title":"Suppressor of cytokine signaling 3 (SOCS-3) protects \u03b2-cells against interleukin-1\u03b2- and interferon-\u03b3-mediated toxicity","volume":"98","author":"Karlsen","year":"2001","journal-title":"Proc Natl Acad Sci"},{"issue":"7039","key":"10.1016\/j.molmet.2025.102218_bib55","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nature03523","article-title":"Prime role for an insulin epitope in the development of type 1 diabetes in NOD mice","volume":"435","author":"Nakayama","year":"2005","journal-title":"Nature"},{"issue":"4630","key":"10.1016\/j.molmet.2025.102218_bib56","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1126\/science.6362005","article-title":"Insulin antibodies in insulin-dependent diabetics before insulin treatment","volume":"222","author":"Palmer","year":"1983","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.molmet.2025.102218_bib57","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200208","article-title":"Safety and dose-response of vidofludimus calcium in relapsing multiple sclerosis: extended results of a placebo-controlled phase 2 trial","volume":"11","author":"Fox","year":"2024","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"4","key":"10.1016\/j.molmet.2025.102218_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002548","article-title":"Genetic scores to stratify risk of developing multiple islet autoantibodies and type 1 diabetes: a prospective study in children","volume":"15","author":"Bonifacio","year":"2018","journal-title":"PLoS Med"},{"issue":"8","key":"10.1016\/j.molmet.2025.102218_bib59","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1038\/s41591-020-0930-4","article-title":"A combined risk score enhances prediction of type 1 diabetes among susceptible children","volume":"26","author":"Ferrat","year":"2020","journal-title":"Nat Med"},{"issue":"2","key":"10.1016\/j.molmet.2025.102218_bib60","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2337\/dc18-1785","article-title":"Development and standardization of an improved type 1 diabetes genetic risk Score for use in newborn screening and incident diagnosis","volume":"42","author":"Sharp","year":"2019","journal-title":"Diabetes Care"},{"issue":"2","key":"10.1016\/j.molmet.2025.102218_bib61","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0092-8674(91)90165-U","article-title":"Virus infection triggers insulin-dependent diabetes mellitus in a transgenic model: role of anti-self (virus) immune response","volume":"65","author":"Oldstone","year":"1991","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.molmet.2025.102218_bib62","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/1074-7613(94)90101-5","article-title":"How virus induces a rapid or slow onset insulin-dependent diabetes mellitus in a transgenic model","volume":"1","author":"von Herrath","year":"1994","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.molmet.2025.102218_bib63","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1089\/dia.2008.0072","article-title":"Murine high specificity\/sensitivity competitive europium insulin autoantibody assay","volume":"11","author":"Babaya","year":"2009","journal-title":"Diabetes Technol Therapeut"}],"container-title":["Molecular Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877825001255?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212877825001255?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T23:00:35Z","timestamp":1758668435000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212877825001255"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":63,"alternative-id":["S2212877825001255"],"URL":"https:\/\/doi.org\/10.1016\/j.molmet.2025.102218","relation":{},"ISSN":["2212-8778"],"issn-type":[{"value":"2212-8778","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of pyrimidine de novo synthesis fosters Treg cells and reduces diabetes development in models of Type 1 Diabetes","name":"articletitle","label":"Article Title"},{"value":"Molecular Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molmet.2025.102218","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"102218"}}